222 related articles for article (PubMed ID: 18784835)
1. Human BLyS facilitates engraftment of human PBL derived B cells in immunodeficient mice.
Schmidt MR; Appel MC; Giassi LJ; Greiner DL; Shultz LD; Woodland RT
PLoS One; 2008 Sep; 3(9):e3192. PubMed ID: 18784835
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response.
Do RK; Hatada E; Lee H; Tourigny MR; Hilbert D; Chen-Kiang S
J Exp Med; 2000 Oct; 192(7):953-64. PubMed ID: 11015437
[TBL] [Abstract][Full Text] [Related]
3. Regulation of human cell engraftment and development of EBV-related lymphoproliferative disorders in Hu-PBL-scid mice.
Wagar EJ; Cromwell MA; Shultz LD; Woda BA; Sullivan JL; Hesselton RM; Greiner DL
J Immunol; 2000 Jul; 165(1):518-27. PubMed ID: 10861091
[TBL] [Abstract][Full Text] [Related]
4. Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator.
Baker KP; Edwards BM; Main SH; Choi GH; Wager RE; Halpern WG; Lappin PB; Riccobene T; Abramian D; Sekut L; Sturm B; Poortman C; Minter RR; Dobson CL; Williams E; Carmen S; Smith R; Roschke V; Hilbert DM; Vaughan TJ; Albert VR
Arthritis Rheum; 2003 Nov; 48(11):3253-65. PubMed ID: 14613291
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor (TNF) receptor superfamily member TACI is a high affinity receptor for TNF family members APRIL and BLyS.
Wu Y; Bressette D; Carrell JA; Kaufman T; Feng P; Taylor K; Gan Y; Cho YH; Garcia AD; Gollatz E; Dimke D; LaFleur D; Migone TS; Nardelli B; Wei P; Ruben SM; Ullrich SJ; Olsen HS; Kanakaraj P; Moore PA; Baker KP
J Biol Chem; 2000 Nov; 275(45):35478-85. PubMed ID: 10956646
[TBL] [Abstract][Full Text] [Related]
6. NF-kappa B1 p50 is required for BLyS attenuation of apoptosis but dispensable for processing of NF-kappa B2 p100 to p52 in quiescent mature B cells.
Hatada EN; Do RK; Orlofsky A; Liou HC; Prystowsky M; MacLennan IC; Caamano J; Chen-Kiang S
J Immunol; 2003 Jul; 171(2):761-8. PubMed ID: 12847243
[TBL] [Abstract][Full Text] [Related]
7. BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2.
Kayagaki N; Yan M; Seshasayee D; Wang H; Lee W; French DM; Grewal IS; Cochran AG; Gordon NC; Yin J; Starovasnik MA; Dixit VM
Immunity; 2002 Oct; 17(4):515-24. PubMed ID: 12387744
[TBL] [Abstract][Full Text] [Related]
8. Expression and occupancy of BAFF-R on B cells in systemic lupus erythematosus.
Carter RH; Zhao H; Liu X; Pelletier M; Chatham W; Kimberly R; Zhou T
Arthritis Rheum; 2005 Dec; 52(12):3943-54. PubMed ID: 16320342
[TBL] [Abstract][Full Text] [Related]
9. Patterns of engraftment in different strains of immunodeficient mice reconstituted with human peripheral blood lymphocytes.
Berney T; Molano RD; Pileggi A; Cattan P; Li H; Ricordi C; Inverardi L
Transplantation; 2001 Jul; 72(1):133-40. PubMed ID: 11468548
[TBL] [Abstract][Full Text] [Related]
10. BLyS BINDS TO B CELLS WITH HIGH AFFINITY AND INDUCES ACTIVATION OF THE TRANSCRIPTION FACTORS NF-kappaB AND ELF-1.
Kanakaraj P; Migone TS; Nardelli B; Ullrich S; Li Y; Olsen HS; Salcedo TW; Kaufman T; Cochrane E; Gan Y; Hilbert DM; Giri J
Cytokine; 2001 Jan; 13(1):25-31. PubMed ID: 11145839
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of BLyS action in B cell immunity.
Do RK; Chen-Kiang S
Cytokine Growth Factor Rev; 2002 Feb; 13(1):19-25. PubMed ID: 11750877
[TBL] [Abstract][Full Text] [Related]
12. Competition for BLyS-mediated signaling through Bcmd/BR3 regulates peripheral B lymphocyte numbers.
Harless SM; Lentz VM; Sah AP; Hsu BL; Clise-Dwyer K; Hilbert DM; Hayes CE; Cancro MP
Curr Biol; 2001 Dec; 11(24):1986-9. PubMed ID: 11747827
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of B lymphocyte stimulator expression by curcumin in B lymphocyte via suppressing nuclear translocation of NF-κB.
Huang G; Yang Y; Xu Z; Zhou P; Gong W; Li Y; Fan J; He F
Eur J Pharmacol; 2011 Jan; 650(1):451-7. PubMed ID: 20950605
[TBL] [Abstract][Full Text] [Related]
14. The role of BLyS/BLyS receptors in anti-chromatin B cell regulation.
Hondowicz BD; Alexander ST; Quinn WJ; Pagán AJ; Metzgar MH; Cancro MP; Erikson J
Int Immunol; 2007 Apr; 19(4):465-75. PubMed ID: 17369193
[TBL] [Abstract][Full Text] [Related]
15. B lymphocytes from individuals with common variable immunodeficiency respond to B lymphocyte stimulator (BLyS protein) in vitro.
Stewart DM; McAvoy MJ; Hilbert DM; Nelson DL
Clin Immunol; 2003 Nov; 109(2):137-43. PubMed ID: 14597212
[TBL] [Abstract][Full Text] [Related]
16. Immunology. Lymphocyte survival--ignorance is BLys.
Laâbi Y; Strasser A
Science; 2000 Aug; 289(5481):883-4. PubMed ID: 10960320
[TBL] [Abstract][Full Text] [Related]
17. TACI-BLyS signaling via B-cell-dendritic cell cooperation is required for naive CD8+ T-cell priming in vivo.
Diaz-de-Durana Y; Mantchev GT; Bram RJ; Franco A
Blood; 2006 Jan; 107(2):594-601. PubMed ID: 16195331
[TBL] [Abstract][Full Text] [Related]
18. Long term substitution and specific immune responses after transfer of bovine peripheral blood lymphocytes into severe combined immunodeficient mice.
Hölscher C; Hasch G; Joswig N; Stauffer U; Müller U; Mossmann H
Vet Immunol Immunopathol; 1999 Sep; 70(1-2):67-83. PubMed ID: 10507288
[TBL] [Abstract][Full Text] [Related]
19. Systemic lupus erythematosus: a blissless disease of too much BLyS (B lymphocyte stimulator) protein.
Stohl W
Curr Opin Rheumatol; 2002 Sep; 14(5):522-8. PubMed ID: 12192248
[TBL] [Abstract][Full Text] [Related]
20. BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator.
Moore PA; Belvedere O; Orr A; Pieri K; LaFleur DW; Feng P; Soppet D; Charters M; Gentz R; Parmelee D; Li Y; Galperina O; Giri J; Roschke V; Nardelli B; Carrell J; Sosnovtseva S; Greenfield W; Ruben SM; Olsen HS; Fikes J; Hilbert DM
Science; 1999 Jul; 285(5425):260-3. PubMed ID: 10398604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]